Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 83,958 | 44,679 | 34,915 | 27,688 | 102,698 |
| Marketable Securities | 19,970 | 38,594 | 61,146 | 61,353 | 7,925 |
| Other current assets | 2,047 | 2,057 | 2,003 | 0 | 0 |
| TOTAL | $113,731 | $99,572 | $111,713 | $98,018 | $115,287 |
| Non-Current Assets | |||||
| PPE Net | 89,023 | 80,875 | 72,541 | 55,864 | 58,615 |
| Investments And Advances | 822 | 1,000 | 8,799 | 10,022 | 9,253 |
| Intangibles | 1,445 | 1,438 | 1,463 | 0 | 0 |
| Other Non-Current Assets | 41,280 | 26,543 | 26,865 | 16,631 | 13,009 |
| TOTAL | $132,570 | $109,856 | $109,668 | $82,517 | $80,877 |
| Total Assets | $246,301 | $209,428 | $221,381 | $180,535 | $196,164 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 35,864 | 37,914 | 26,348 | 7,516 | 6,199 |
| Accrued Expenses | 36,134 | 36,793 | 36,771 | 5,497 | 7,449 |
| Other current liabilities | N/A | N/A | N/A | 2,299 | 3,401 |
| TOTAL | $74,428 | $79,863 | $68,134 | $20,663 | $17,049 |
| Non-Current Liabilities | |||||
| Long Term Debt | 300,252 | 297,286 | 254,353 | N/A | N/A |
| Other Non-Current Liabilities | 31,133 | 18,312 | 18,016 | 11,817 | 10,040 |
| TOTAL | $330,458 | $314,901 | $271,737 | $11,250 | $9,462 |
| Total Liabilities | $404,886 | $394,764 | $339,871 | $31,913 | $26,511 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 391,157 | 383,906 | 109,345 | 108,593 | 107,971 |
| Common Shares | 39 | 38 | 38 | 11 | 11 |
| Retained earnings | -1,783,033 | -1,694,745 | -1,615,131 | -722,442 | -700,666 |
| Other shareholders' equity | -609 | 413 | 1,440 | -117 | -100 |
| TOTAL | $-158,585 | $-185,336 | $-118,490 | $148,622 | $169,653 |
| Total Liabilities And Equity | $246,301 | $209,428 | $221,381 | $180,535 | $196,164 |